Articles From: D.R. Horton's profit rises, but falls short of expectations to Web.com Study Reveals Online Security Concerns Are Driving Consumers to Shop Small Businesses This Holiday Season


2014/11/11
Sign-up for D.R. Horton's profit rises, but falls short of expectations investment picks
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- Here are some companies whose shares are making notable moves in European trade on Tuesday.
Sign-up for Vodafone jumps; Fugro slides: Europe's big stock movers investment picks
Markit | Genpact KYC Services, the joint venture from Markit Ltd.
Sign-up for Markit | Genpact KYC Services Registers 600+ Firms and Appoints CEO investment picks
Trial expands the eligible patient population and overall NeuVax clinical trial portfolio Recent patent allowance provides intellectual property protection for NeuVax in combination with Herceptin in any HER2/neu expressing cancer PORTLAND, Ore., Nov.
Sign-up for Galena Biopharma Doses First Patient in Phase 2 Clinical Trial With NeuVax(TM) (nelipepimut-S) in Combination With Herceptin(R) (trastuzumab) to Treat High-Risk HER2 3+ or HER2 Gene-Amplified Breast Cancer Patients investment picks
2014/11/11
Study finds the median-income household could generate more than 50 percent more net wealth over the next 10 years by renting and investing instead of buying a home.
Sign-up for House of Cards: Morningstar's HelloWallet Unit Examines How Buying a Home vs. Renting and Investing Affects Wealth Creation investment picks
SAN DIEGO, Nov.
Sign-up for Conatus Pharmaceuticals to Present at Stifel 2014 Healthcare Conference investment picks
NEW YORK and BAGHDAD, Iraq, Nov.
Sign-up for Iraq Stock Exchange Launches Nasdaq's X-stream Trading Technology investment picks
2014/11/11
SHANGHAI , Nov.
Sign-up for Taomee Holdings Limited to Host Third Quarter 2014 Earnings Conference Call on Tuesday, November 25, 2014 investment picks
Demandware ®, Inc. (NYSE: DWRE), the industry-leading provider of enterprise cloud commerce solutions, today announced that the company will present at the following conference: UBS Global Technology Conference Tim Adams, Demandware Chief Financial Officer, will present on Thursday, November 20 th at 8:30 a.m. PST at Cavallo Point, The Lodge at the Golden Gate An audio webcast of the presentation will be available on Demandware’s investor relations website at http://investors.demandware.com .
Sign-up for Demandware Executive to Present at Upcoming Investor Conference investment picks
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will present a corporate overview at the Stifel 2014 Healthcare Conference, November 18, 2014 at 1:50 p.m. EST at The New York Palace Hotel in New York City.
Sign-up for Concert Pharmaceuticals to Present at Stifel 2014 Healthcare Conference on November 18, 2014 investment picks
AECOM Technology Corporation (NYSE:ACM), the world’s #1-ranked engineering design firm, reported fourth-quarter revenue of $2.6 billion and net service revenue 1 , of $1.3 billion.
Sign-up for AECOM reports fourth-quarter, full-year fiscal year 2014 results investment picks
AES Eletropaulo markedly reduces call volume and lowers processing time for a fast ROI RA'ANANA, Israel , November 11, 2014 /PRNewswire/ -- NICE Systems (NASDAQ: NICE) today announced that AES Eletropaulo, a major power distributor in Brazil , has deployed NICE Real-Time Process Optimization in its contact center to improve operational efficiency, lower the number of repeat calls, and reduce average processing time.
Sign-up for Brazil's AES Eletropaulo Deploys NICE Real-Time Solutions to Significantly Improve Operational Efficiency investment picks
HOUSTON , Nov.
Sign-up for Main Street Announces New Portfolio Investment investment picks
Charles & Colvard, Ltd.
Sign-up for Charles & Colvard to Present at the Southwest IDEAS Investor Conference on November 19th in Dallas investment picks
2014/11/11
MEF GEN14 — Transition Networks , Inc., the fiber access technology expert, a wholly owned subsidiary of Communications Systems, Inc. (NASDAQ-GM: JCS), announced that it will be actively participating in the MEF GEN14 event being held November 17-20 in Washington D.C. MEF GEN14 is a global Ethernet networking event for industry professionals involved in all aspects of state-of-the-art innovations powered by Carrier Ethernet, SDN, NFV and optical networking.
Sign-up for Transition Networks to Present Key Carrier Ethernet Solution Innovations at MEF GEN14 Show in Washington DC investment picks
HOUSTON , Nov.
Sign-up for Rowan Companies Appoints New Chief Financial Officer investment picks
Trevena, Inc. (NASDAQ: TRVN), a clinical stage biopharmaceutical company focused on the discovery and development of G protein coupled receptor (GPCR) biased ligands, today announced financial results for the quarter ended September 30, 2014 and provided an update regarding its ongoing clinical programs.
Sign-up for Trevena Reports Third Quarter 2014 Financial Results and Provides a Corporate Update investment picks
Integration of Samsung's mobile innovations with the SAP Mobile Platform will help unlock new possibilities for developers and enterprise customers across key industries SEOUL, South Korea , and BERLIN , Nov.
Sign-up for Samsung and SAP Announce Plans to Collaborate and Deliver Innovative Enterprise Solutions on Mobile Devices and Wearables for Key Industries investment picks
ALBANY, N.Y., Nov.
Sign-up for AngioDynamics to Present at Upcoming Investor Conferences investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0978263001&sourceType=1 http://www.ccnmatthews.com/logos/20051018-prometic.gif LAVAL, QUEBEC --
Sign-up for ProMetic's PBI-4050 Cleared to Commence Clinical Trials in Patients with Diabetic Kidney Disease investment picks
2014/11/11
By Barbara Kollmeyer, MarketWatch No.
Sign-up for 'Words with Friends' earns Zynga a buy rating at Jefferies investment picks
Genesee & Wyoming Inc. (G&W) (NYSE:GWR) today reported traffic volumes for October 2014.
Sign-up for Genesee & Wyoming Reports Traffic for October 2014 investment picks
Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced that Dave Stack, president, chief executive officer and chairman of Pacira Pharmaceuticals, is scheduled to present at the Jefferies 2014 Global London Healthcare Conference at 10:40 a.m. GMT (5:40 a.m. ET) on Wednesday, Nov.
Sign-up for Pacira Pharmaceuticals, Inc. to Present at the Jefferies 2014 Global London Healthcare Conference investment picks
Teammates across the country celebrate and commemorate veteran military personnel for Veterans Day DENVER , Nov.
Sign-up for DaVita HealthCare Partners Honors and Supports Service Members investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: D.R. Horton's profit rises, but falls short of expectations to Web.com Study Reveals Online Security Concerns Are Driving Consumers to Shop Small Businesses This Holiday Season
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent